This Article Full Text Full Text (PDF) All Versions of this Article: 24/10/1848    most recent 01.ATV.0000142364.85911.0ev1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fujimoto, H. Articles by Nagai, R. Search for Related Content PubMed PubMed Citation Articles by Fujimoto, H. Articles by Nagai, R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CARBON MONOXIDE Related Collections Animal models of human disease Cell signalling/signal transduction Ischemic biology - basic studies Other Treatment Acute myocardial infarction Oxidant stress Endothelium/vascular type/nitric oxide

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:1848.)
© 2004 American Heart Association, Inc.

Vascular Biology

Carbon Monoxide Protects Against Cardiac Ischemia—Reperfusion Injury In Vivo via MAPK and Akt—eNOS Pathways

Hajime Fujimoto; Minoru Ohno; Seiji Ayabe; Hisae Kobayashi; Nobukazu Ishizaka; Hiroko Kimura; Ken-ichi Yoshida; Ryozo Nagai

From the Department of Cardiovascular Medicine (H.F., M.O., S.A., H.K., N.I., R.N.), University of Tokyo; the Department of Forensic Medicine (H.K.), School of Medicine, Juntendo University, Tokyo; and the Department of Forensic Medicine (K.-i.Y.), the University of Tokyo, Japan.

Correspondence to Dr Minoru Ohno, Department of Cardiovascular Medicine, the University of Tokyo, Graduate School of Medicine, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. E-mail mino-tky{at}umin.ac.jp

Background— Carbon monoxide (CO) is postulated to protect tissues against several types of injuries. We investigated the role of CO in amelioration of cardiac ischemia–reperfusion injury in vivo and the mechanisms involved in it.

Methods and Results— Rats inhaled CO (250 ppm, 500 ppm, or 1000 ppm) for 24 hours in a chamber after myocardial ischemia–reperfusion induced by occluding the left anterior descending coronary artery for 30 minutes. Pre-exposure to 1000 ppm of CO significantly reduced the ratio of infarct areas to risk areas and suppressed the migration of macrophages and monocytes into infarct areas, and the expression of tumor necrosis factor (TNF)- in the heart; however, 250 ppm, 500 ppm of CO, or low barometric pressure hypoxia (0.5 atm) did not affect them. Exposure to 1000 ppm CO resulted in the activation of p38 mitogen-activated protein kinase (p38MAPK), protein kinase B(Akt), endothelial nitric oxide synthase (eNOS), and cyclic guanosine monophosphate (cGMP) in the myocardium. Inhibition of p38MAPK, PI3kinase, NO, and soluble guanylate cyclase with SB203580, wortmannin, N(G)-nitro-L-arginine methyl ester (L-NAME), and methylene blue, respectively, attenuated the cytoprotection by CO.

Conclusion— CO has beneficial effects on cardiac ischemia–reperfusion injury; this effect is mediated by p38MAPK pathway and Akt–eNOS pathway, including production of cGMP.

The role of carbon monoxide (CO) in myocardial ischemia–reperfusion was studied. Pre-inhalation of 1000 ppm CO reduced cardiac ischemia–reperfusion injury in vivo. CO resulted in phosphorylation of p38MAPK, Akt, and eNOS. Inhibition of these pathways attenuated the cytoprotection by CO. Thus, CO protects against ischemia–reperfusion by activating p38MAPK, Akt, and eNOS.

Key Words: ischemia • ischemic heart disease • nitric oxide synthase • pharmacokinetics • reperfusion injury

This article has been cited by other articles:

				J. D. Beckman, J. D. Belcher, J. V. Vineyard, C. Chen, J. Nguyen, M. O. Nwaneri, M. G. O'Sullivan, E. Gulbahce, R. P. Hebbel, and G. M. Vercellotti Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell disease Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1243 - H1253. [Abstract] [Full Text] [PDF]

				G. Czibik, J. Sagave, V. Martinov, B. Ishaq, M. Sohl, I. Sefland, H. Carlsen, F. Farnebo, R. Blomhoff, and G. Valen Cardioprotection by hypoxia-inducible factor 1 alpha transfection in skeletal muscle is dependent on haem oxygenase activity in mice Cardiovasc Res, April 1, 2009; 82(1): 107 - 114. [Abstract] [Full Text] [PDF]

				W.-H. Kan, J.-T. Hsu, Z.-F. Ba, M. G. Schwacha, J. Chen, M. A. Choudhry, K. I. Bland, and I. H. Chaudry p38 MAPK-dependent eNOS upregulation is critical for 17{beta}-estradiol-mediated cardioprotection following trauma-hemorrhage Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2627 - H2636. [Abstract] [Full Text] [PDF]

				A. Kobayashi, K. Ishikawa, H. Matsumoto, S. Kimura, Y. Kamiyama, and Y. Maruyama Synergetic Antioxidant and Vasodilatory Action of Carbon Monoxide in Angiotensin II Induced Cardiac Hypertrophy Hypertension, December 1, 2007; 50(6): 1040 - 1048. [Abstract] [Full Text] [PDF]

				X. Liu, J. A. Simpson, K. R. Brunt, C. A. Ward, S. R. R. Hall, R. T. Kinobe, V. Barrette, M. Y. Tse, S. C. Pang, A. S. Pachori, et al. Preemptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function 1 yr after acute myocardial infarction Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H48 - H59. [Abstract] [Full Text] [PDF]

				J.-T. Hsu, Y.-C. Hsieh, W. H. Kan, J. G. Chen, M. A. Choudhry, M. G. Schwacha, K. I. Bland, and I. H. Chaudry Role of p38 mitogen-activated protein kinase pathway in estrogen-mediated cardioprotection following trauma-hemorrhage Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2982 - H2987. [Abstract] [Full Text] [PDF]

				F. Gueler, J.-K. Park, S. Rong, T. Kirsch, C. Lindschau, W. Zheng, M. Elger, A. Fiebeler, D. Fliser, F. C. Luft, et al. Statins Attenuate Ischemia-Reperfusion Injury by Inducing Heme Oxygenase-1 in Infiltrating Macrophages Am. J. Pathol., April 1, 2007; 170(4): 1192 - 1199. [Abstract] [Full Text] [PDF]

				S. W. Ryter, D. Morse, and A. M. K. Choi Carbon Monoxide and Bilirubin: Potential Therapies for Pulmonary/Vascular Injury and Disease Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 175 - 182. [Abstract] [Full Text] [PDF]

				B. S. Zuckerbraun, B. Y. Chin, B. Wegiel, T. R. Billiar, E. Czsimadia, J. Rao, L. Shimoda, E. Ifedigbo, S. Kanno, and L. E. Otterbein Carbon monoxide reverses established pulmonary hypertension J. Exp. Med., September 4, 2006; 203(9): 2109 - 2119. [Abstract] [Full Text] [PDF]

				M. Massip-Salcedo, A. Casillas-Ramirez, R. Franco-Gou, R. Bartrons, I. Ben Mosbah, A. Serafin, J. Rosello-Catafau, and C. Peralta Heat Shock Proteins and Mitogen-activated Protein Kinases in Steatotic Livers Undergoing Ischemia-Reperfusion: Some Answers Am. J. Pathol., May 1, 2006; 168(5): 1474 - 1485. [Abstract] [Full Text] [PDF]

				M. V. Cohen, X.-M. Yang, and J. M. Downey Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies Cardiovasc Res, May 1, 2006; 70(2): 231 - 239. [Abstract] [Full Text] [PDF]

				L. Wu and R. Wang Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications Pharmacol. Rev., December 1, 2005; 57(4): 585 - 630. [Abstract] [Full Text] [PDF]